Theator (תיאטור איי.אל בע"מ)

San Mateo, California, United States

Theator is developing a SaaS platform to provide surgeons with AI-powered decision-support tools. Theator is helping surgeons improve performance by leveraging machine learning and computer vision to identify, optimize, and scale dissemination of best practices. The company's long-term vision is to enhance surgeon performance in real time and build a cognitive base to enable autonomous surgical robotic platforms. Theator's first product, Minutes, is a highlight reel and analytics tool, providing intelligently edited versions of surgical procedures. These are presented to surgeons in a palatable and actionable form in order to help quickly and efficiently prepare and debrief using AI-powered algorithmic insights. The product is based on a real-world dataset and comprised of two general modules for surgeons: a content-management software and a visual operative report with analytics. Minutes houses and analyzes video data from surgical procedures and is intended to be utilized by surgeons to review and analyze prior surgeries for educational purposes only. Minutes does not provide real-time feedback to the surgeon during surgery and is not intended for use in making treatment decisions for patients.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Theator (תיאטור איי.אל בע"מ) on @MedStartr Today #SurgicalSpecialties #AIML #MedMo #MedStartrVentures

https://www.medstartr.ai/s/90CXwHwW62E

Get Involved in Theator (תיאטור איי.אל בע"מ)

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2018
Website: theator.io/

Disease Areas

Surgical Specialties

Technologies

SaaSAI-poweredMachine LearningComputer Vision

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Theator (תיאטור איי.אל בע"מ)?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.